We are live on ! Find out more
MCM

Mengis Capital Management Portfolio holdings

AUM $581M
1-Year Est. Return 28.04%
This Fund
S&P 500
This Quarter Est. Return
+1.85%
1 Year Est. Return
+28.04%
3 Year Est. Return
+72.9%
5 Year Est. Return
+105.39%
10 Year Est. Return
+334.2%
AUM
$113M
AUM Growth
+$5.18M
Cap. Flow
+$3.72M
Cap. Flow %
3.28%
Top 10 Hldgs %
30.21%
Holding
109
New
6
Increased
47
Reduced
33
Closed
5

Top Buys

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$1.44M
2
MRK icon
Merck
MRK
+$664K
3
TGT icon
Target
TGT
+$593K
4
QCOM icon
Qualcomm
QCOM
+$435K
5
GE icon
GE Aerospace
GE
+$409K

Top Sells

Rank Stock Value
1
NWN icon
Northwest Natural Holdings
NWN
+$661K
2
BAX icon
Baxter International
BAX
+$431K
3
INTC icon
Intel
INTC
+$322K
4
BXLT
BAXALTA INC COM STK (DE)
BXLT
+$313K
5
NTI
NORTHERN TIER ENERGY LP CLASS A
NTI
+$259K

Sector Composition

Rank Sector Weight
1 Technology 15.47%
2 Healthcare 14.25%
3 Energy 10.53%
4 Financials 9.72%
5 Consumer Staples 9.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCAR icon
51
PACCAR
PCAR
$70.2B
$671K 0.59%
19,425
+2,250
+13% +$82.7K
KMI icon
52
Kinder Morgan
KMI
$70.6B
$666K 0.59%
35,603
-1,283
-3% -$22.9K
MPT
53
Medical Properties Trust
MPT
$2.86B
$664K 0.59%
43,720
+9
+0% +$127
JPM.PRD.CL
54
DELISTED
JPMorgan Chase & Co.
JPM.PRD.CL
$663K 0.58%
25,600
– –
SBUX icon
55
Starbucks
SBUX
$118B
$657K 0.58%
11,505
+15
+0.1% +$853
WFC icon
56
Wells Fargo
WFC
$264B
$657K 0.58%
13,901
+30
+0.2% +$1.46K
RDS.A
57
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$643K 0.57%
11,645
-1,800
-13% -$91.6K
GILD icon
58
Gilead Sciences
GILD
$162B
$624K 0.55%
7,485
+475
+7% +$42.2K
BIDU icon
59
Baidu
BIDU
$35.8B
$601K 0.53%
3,645
+100
+3% +$17.6K
BSV icon
60
Vanguard Short-Term Bond ETF
BSV
$44.6B
$555K 0.49%
6,848
-2,565
-27% -$207K
TGT icon
61
Target
TGT
$63.7B
$555K 0.49%
+7,950
New +$593K
WMB icon
62
Williams Companies
WMB
$86.6B
$541K 0.48%
25,015
– –
DEM icon
63
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.88B
$531K 0.47%
14,996
-851
-5% -$29.4K
SCHM icon
64
Schwab US Mid-Cap ETF
SCHM
$14.6B
$507K 0.45%
36,228
+1,011
+3% +$13.9K
SCHD icon
65
Schwab US Dividend Equity ETF
SCHD
$103B
$489K 0.43%
35,454
+2,415
+7% +$32.6K
SYY icon
66
Sysco
SYY
$40.2B
$470K 0.41%
9,280
-1,100
-11% -$53.2K
SPY icon
67
State Street SPDR S&P 500 ETF Trust
SPY
$781B
$461K 0.41%
2,200
+26
+1% +$5.39K
CMI icon
68
Cummins
CMI
$91.3B
$455K 0.4%
4,050
+1,150
+40% +$130K
MMP
69
DELISTED
Magellan Midstream Partners, L.P.
MMP
$448K 0.4%
5,900
– –
GLW icon
70
Corning
GLW
$123B
$447K 0.39%
21,850
+1,700
+8% +$34.1K
BKNG icon
71
Booking.com
BKNG
$145B
$436K 0.38%
8,750
+1,875
+27% +$97.3K
MDT icon
72
Medtronic
MDT
$108B
$433K 0.38%
4,996
– –
WBA
73
DELISTED
Walgreens Boots Alliance
WBA
$423K 0.37%
5,090
-1,500
-23% -$121K
PCBK
74
DELISTED
Pacific Continental Corp
PCBK
$416K 0.37%
26,526
-8,998
-25% -$147K
IWM icon
75
iShares Russell 2000 ETF
IWM
$80.3B
$407K 0.36%
3,544
-500
-12% -$56.4K
1 2
3
4 5

Similar funds

TCM
Trybe Capital Management Greenwich, Connecticut $581M AUM 112.96% 1-Year Est. Return
JCP
JB Capital Partners Armonk, New York $581M AUM 46.16% 1-Year Est. Return
AF
Aegis Financial Mc Lean, Virginia $580M AUM 105.74% 1-Year Est. Return
TCMX
Technology Crossover Management XI Menlo Park, California $582M AUM 17.87% 1-Year Est. Return
DLCIG
D.L. Carlson Investment Group Concord, New Hampshire $582M AUM 29.47% 1-Year Est. Return
GF
Goodman Financial Houston, Texas $582M AUM 22.09% 1-Year Est. Return
IIA
IPG Investment Advisors San Diego, California $582M AUM 33.22% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Mengis Capital Management's Q2 2016 Portfolio in Review

As of Q2 2016, Mengis Capital Management held 109 positions worth $113M, up 4.8% from $108M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Mengis Capital Management deployed $3.72M of net new capital in Q2 2016, opening 6 new positions and adding to 47 existing holdings. Its largest new stake was Allergan Inc: 6,210 shares worth $1.44M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was Northwest Natural Holdings, an estimated $661K trimmed.

  • Mengis Capital Management's largest Q2 2016 buy was Allergan Inc: 6,210 shares worth $1.44M.
  • Mengis Capital Management added most to Merck in Q2 2016, an estimated $664K increase.
  • Mengis Capital Management's biggest Q2 2016 reduction was Northwest Natural Holdings, cutting an estimated $661K.
  • Mengis Capital Management fully exited Baxter International in Q2 2016, selling an estimated $431K.
  • Mengis Capital Management's ten largest holdings make up 30% of its $113M portfolio in Q2 2016.
  • Mengis Capital Management opened 6 new positions and closed 5 in Q2 2016.
  • Mengis Capital Management's portfolio value rose 4.8% quarter-over-quarter to $113M.

Based on Mengis Capital Management's 13F filing for Q2 2016, filed 8 Aug 2016.